Skip to main content
. 2022 Mar 22;6(4):ytac130. doi: 10.1093/ehjcr/ytac130

Figure 3.

Figure 3

Trends of brain natriuretic peptide (pg/mL), immunoglobulin G lambda (mg/dL) and peak maximal oxygen consumption during exercise (% of predicted value) during follow up. cyclophosphamide, bortezomib, and dexamethasone combined therapy administered between February and June 2018.